Literature DB >> 15506837

Retrograde amnesia in dementia: comparison of HIV-associated dementia, Alzheimer's disease, and Huntington's disease.

Joseph R Sadek1, Shannon A Johnson, Desirée A White, David P Salmon, Kirsten I Taylor, Jody H Delapena, Jane S Paulsen, Robert K Heaton, Igor Grant.   

Abstract

Remote memory was assessed in persons with HIV-associated dementia (HIV-D), probable Alzheimer's disease (AD), and Huntington's disease (HD) and in healthy controls. The clinical groups were similar in overall dementia severity. Each clinical group exhibited impairments on remote memory tests relative to controls; however, temporally graded memory loss with selective preservation of older information was observed in the AD group but not the HD or HIV-D group. Analysis of cued retrieval indicated a preferential cuing benefit for the HIV-D and HD groups relative to the AD group. The similar pattern of remote memory performance demonstrated by the HIV-D and HD groups is a novel finding and suggests a subcortically mediated retrograde amnesia in HIV-D. The temporally graded pattern and the abnormal cued retrieval performance in the AD group are consistent with a consolidation deficit associated with extrahippocampal (cortical) and hippocampal damage.

Entities:  

Mesh:

Year:  2004        PMID: 15506837     DOI: 10.1037/0894-4105.18.4.692

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  18 in total

Review 1.  Neuropsychological assessment of dementia.

Authors:  David P Salmon; Mark W Bondi
Journal:  Annu Rev Psychol       Date:  2009       Impact factor: 24.137

Review 2.  "Pre-symptomatic" Huntington's disease.

Authors:  Kevin Duff; Leigh J Beglinger; Jane S Paulsen
Journal:  Handb Clin Neurol       Date:  2008

3.  Influence of procedural learning on Iowa Gambling Task performance among HIV+ individuals with history of substance dependence.

Authors:  Raul Gonzalez; Margaret Wardle; Joanna Jacobus; Jasmin Vassileva; Eileen M Martin-Thormeyer
Journal:  Arch Clin Neuropsychol       Date:  2009-11-25       Impact factor: 2.813

4.  Estimating Contact Exposure in Football Using the Head Impact Exposure Estimate.

Authors:  Zachary Y Kerr; Ashley C Littleton; Leah M Cox; J D DeFreese; Eleanna Varangis; Robert C Lynall; Julianne D Schmidt; Stephen W Marshall; Kevin M Guskiewicz
Journal:  J Neurotrauma       Date:  2015-04-01       Impact factor: 5.269

5.  Remote semantic memory for public figures in HIV infection, alcoholism, and their comorbidity.

Authors:  Rosemary Fama; Margaret J Rosenbloom; Stephanie A Sassoon; Megan A Thompson; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Alcohol Clin Exp Res       Date:  2010-12-01       Impact factor: 3.455

Review 6.  Cognitive impairment in Huntington disease: diagnosis and treatment.

Authors:  Jane S Paulsen
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

7.  Deficits in complex motor functions, despite no evidence of procedural learning deficits, among HIV+ individuals with history of substance dependence.

Authors:  Raul Gonzalez; Joanna Jacobus; Anup K Amatya; Phillip J Quartana; Jasmin Vassileva; Eileen M Martin
Journal:  Neuropsychology       Date:  2008-11       Impact factor: 3.295

Review 8.  Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's Disease.

Authors:  S DeVaughn; E M Müller-Oehring; B Markey; H M Brontë-Stewart; T Schulte
Journal:  Neuropsychol Rev       Date:  2015-11-17       Impact factor: 7.444

9.  Visuospatial and Attentional Abilities Predict Driving Simulator Performance Among Older HIV-infected Adults.

Authors:  J M Foley; A L Gooding; A D Thames; M L Ettenhofer; M S Kim; S A Castellon; T D Marcotte; J R Sadek; R K Heaton; W G van Gorp; C H Hinkin
Journal:  Am J Alzheimers Dis Other Demen       Date:  2013-01-11       Impact factor: 2.035

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.